Christie Perelló

2.1k total citations · 2 hit papers
33 papers, 1.1k citations indexed

About

Christie Perelló is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Christie Perelló has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 24 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in Christie Perelló's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (13 papers) and Liver Disease and Transplantation (11 papers). Christie Perelló is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (13 papers) and Liver Disease and Transplantation (11 papers). Christie Perelló collaborates with scholars based in Spain, Argentina and United States. Christie Perelló's co-authors include José Luís Calleja, Jordi Bruix, Marı́a Varela, María Reig, Sabela Lens, Bruno Sangro, Xavier Forns, Zoe Mariñó, Mercedes Iñarrairaegui and Anna Darnell and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Christie Perelló

28 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

2016 725 citations María Reig, Zoe Mariñó et al. Journal of Hepatology profile →
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease

2024 65 citations David Martí‐Aguado, José Luís Calleja et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christie Perelló Spain	11	914	875	67	67	66	33	1.1k
Hung‐Da Tung Taiwan	21	1.1k 1.2×	1.1k 1.3×	67 1.0×	88 1.3×	46 0.7×	47	1.3k
Silvia Gaia Italy	17	783 0.9×	740 0.8×	122 1.8×	42 0.6×	73 1.1×	60	1.1k
Jean-Pierre Bronowicki France	13	738 0.8×	520 0.6×	89 1.3×	60 0.9×	74 1.1×	18	894
Amr El Fouly Egypt	8	657 0.7×	427 0.5×	45 0.7×	38 0.6×	48 0.7×	14	773
Mitsuaki Sato Japan	10	463 0.5×	436 0.5×	51 0.8×	35 0.5×	42 0.6×	35	581
Hideyuki Fusamoto Japan	14	703 0.8×	585 0.7×	51 0.8×	24 0.4×	89 1.3×	21	868
Matthias Dollinger Germany	15	376 0.4×	358 0.4×	25 0.4×	28 0.4×	57 0.9×	28	576
Leona Dold Germany	11	255 0.3×	248 0.3×	78 1.2×	32 0.5×	89 1.3×	35	513
Shozo Miyake Japan	16	437 0.5×	356 0.4×	47 0.7×	62 0.9×	69 1.0×	38	643
S. Hadziyannis Greece	10	666 0.7×	634 0.7×	44 0.7×	29 0.4×	24 0.4×	18	776

Countries citing papers authored by Christie Perelló

Since Specialization

Citations

This map shows the geographic impact of Christie Perelló's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christie Perelló with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christie Perelló more than expected).

Fields of papers citing papers by Christie Perelló

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christie Perelló. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christie Perelló. The network helps show where Christie Perelló may publish in the future.

Co-authorship network of co-authors of Christie Perelló

This figure shows the co-authorship network connecting the top 25 collaborators of Christie Perelló. A scholar is included among the top collaborators of Christie Perelló based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christie Perelló. Christie Perelló is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martí‐Aguado, David, José Luís Calleja, Eduardo Vilar‐Gómez, et al.. (2024). Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease. Journal of Hepatology. 81(6). 930–940. 65 indexed citations breakdown →

Martí‐Aguado, David, José Luís Calleja, Eduardo Vilar‐Gómez, et al.. (2024). FRI-213 Low-to-moderate alcohol consumption is associated with increased fibrosis in subjects with metabolic dysfunction-associated steatotic liver disease. Journal of Hepatology. 80. S469–S469. 2 indexed citations

Calvo, Mariona, Marı́a Varela, Neus Llarch, et al.. (2023). Interim analysis of the ACTION trial: Cabozantinib for hepatocellular carcinoma patients who discontinued first line treatment other than sorafenib or due to sorafenib intolerance. Journal of Hepatology. 78. S579–S580.

Llop, Elba, Christie Perelló, Teresa Fontanilla, et al.. (2022). Spleen Transient Elastography and Damping Index Identify a Subgroup of Patients Without an Acute or Chronic Response to Beta-Blockers. Frontiers in Medicine. 9. 900073–900073. 3 indexed citations

Llop, Elba, Paula Iruzubieta, Christie Perelló, et al.. (2021). High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort. United European Gastroenterology Journal. 9(8). 892–902. 20 indexed citations

Cuadrado, Antonio, Christie Perelló, Joaquín Cabezas, et al.. (2020). Update on epidemiology of hepatitis B in a low‐endemic European country: There is still much to do. Journal of Viral Hepatitis. 27(11). 1261–1265. 11 indexed citations

Rimola, Jordi, Leonardo Gomes da Fonseca, Víctor Sapena, et al.. (2020). Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice. European Journal of Radiology. 135. 109484–109484. 20 indexed citations

Llop, Elba, Carlos Fernández‐Carrillo, Christie Perelló, et al.. (2020). A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis. Journal of Hepatology. 73. S743–S743. 1 indexed citations

Ibáñez, Luis, Carlos Fernández‐Carrillo, Míriam Romero, et al.. (2020). Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19. The Journal of Infectious Diseases. 222(5). 726–733. 46 indexed citations

10.

Llop, Elba, Carlos Fernández‐Carrillo, Javier Abad, et al.. (2020). Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology. 26(42). 6658–6668. 13 indexed citations

11.

Crespo, Javier, Antonio Cuadrado, Christie Perelló, et al.. (2019). Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain. Journal of Viral Hepatitis. 27(4). 360–370. 37 indexed citations

12.

Llop, Elba, Carlos Fernández‐Carrillo, Christie Perelló, et al.. (2019). Visceral fat is associated with cirrhotic portal vein thrombosis. Expert Review of Gastroenterology & Hepatology. 13(10). 1017–1022. 6 indexed citations

13.

Perelló, Christie, Elba Llop, Inmaculada Fernández, et al.. (2019). FRI-496-Recurrence of hepatocellular carcinoma in patients with complete response treated with direct acting antivirals in clinical practice. Journal of Hepatology. 70(1). e617–e617.

14.

Llop, Elba, Paula Iruzubieta, Christie Perelló, et al.. (2018). Transient elastography as a screening method for chronic liver disease in apparently healthy population. Results from de ETHON cohort. Journal of Hepatology. 68. S634–S634. 1 indexed citations

15.

Fernández‐Carrillo, Carlos, et al.. (2018). Impact of Sustained Viral Response in the Evolution of Minimal Hepatic Encephalopathy: a Prospective Pilot Study. Annals of Hepatology. 18(1). 203–208. 1 indexed citations

16.

Calleja, José Luís, Susana Llerena, Christie Perelló, & Javier Crespo. (2016). NS5A Resistance: Clinical Implications and Treatment Possibilities.. PubMed. 18(1). 15–22. 5 indexed citations

17.

Reig, María, Zoe Mariñó, Christie Perelló, et al.. (2016). Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution. 65 indexed citations

18.

Reig, María, Zoe Mariñó, Christie Perelló, et al.. (2016). Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. Journal of Hepatology. 65(4). 719–726. 725 indexed citations breakdown →

19.

Londoño, María‐Carlota, Christie Perelló, Joaquín Cabezas, et al.. (2014). P1135 ADDITION OF TELAPREVIR OR BOCEPREVIR TO PEG-RIB THERAPY INCREASES THE RISK OF INFECTIONS IN PATIENTS WITH HEPATITIS C-RELATED CIRRHOSIS (HCV-CH): A COMPARATIVE STUDY. Journal of Hepatology. 60(1). S460–S460.

20.

Londoño, María‐Carlota, Christie Perelló, Joaquín Cabezas, et al.. (2014). The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis. Journal of Hepatology. 62(2). 311–316. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact